FLAVYA™

Product Description

Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.
Two variants for tailored treatment:

Excellence (44 mg HA, 2.2%, 100–200 Pas) for thicker skin/deeper wrinkles, injected into deep/medium-deep dermis; Medium (32 mg HA, 1.6%, <100 Pas) for thin, delicate skin, injected into the reticular dermis

Biovico Sp. z o.o.

Country/Region:

Poland
Founded:

2008
On CPHI since:

2015
Certificates:

5
Employees:

100 - 249

Company types

CMO/CDMO

Licensee

Manufacturer/Innovator

Wholesale/Retail

Primary activities

Medical Devices

Compare Add to favorites Added to favorites

Specifications

Details

Flavya™ products are designed, in order to increase the ability of water-binding in the skin, to improve skin hydration, elasticity and density, for protection of cells against free radicals, cells revitalization and accelerate wound healing by initiating collagen and elastin synthesis.Application areas - face, neck, decollete.
Selling Points
Packaging; FLAVYA™ – Non-crosslinked skinbooster
Bio-identical, native HMW-HA (1800–2500 kDa) via bacterial fermentation – sterile, non-pyrogenic, unmodified chemical structure naturally present in the skin's ECM
Controlled biodegradation into LMW-HA fragments that actively stimulate collagen and elastin production, driving fibroblast activity and skin rehydration
Clinically proven: +21% dermal thickness on average (ultrasound-confirmed, up to ~35% increase in study), improved hydration, elasticity, radiance and smoothness
Simple protocol: 3–5 sessions, once weekly max, repeatable after 6 months; 2 mL pre-filled syringe

Supplied from

Poland